Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breastcancer. "We achieved key milestones during the quarter against our ... HEAT trial (ThermoDox global Phase III HCC study) to the Asia Pacific region where the incidence of primary liver cancer is endemic. We recently received regulatory approval to treat ...
2009 NOV 16 ... 60 patients with diagnosis of lymphoma, myeloma, sarcoma, acute leukemia, and breastcancer were accrued. They were all receiving multiday chemotherapy regimens. The first ... to the drug or any of its components. The most commonly reported adverse reactions (incidence ≥ 2 percent) in CINV trials with palonosetron were headache (9 percent) and ...
2009 NOV 23 ... family history of cancer generally or any of the other cancers investigated (lung, breast, prostate, gastric, esophageal, endometrial, ovarian, urinary tract, central nervous ... Chinese women. We followed 73,358 women in the Shanghai Women's Health Study for cancer incidence until December 2005. After an average of 7 years of follow-up, 391 women were diagnosed ...
2009 NOV 16 ... consistent with the findings of the concurrent mortality study. An increased risk of breastcancer was detected in zone A females after 15 years since the accident (five cases, RR, ... (TCDD). Possible long-term effects have been examined through mortality and cancer incidence studies," scientists in Milan, Italy report. "We have updated the cancer ...
2009 NOV 23 ... largest contributions to the overall gap were seen in the treatment of cancers of the breast (6%) (modelled at 15 fractions), head and neck (10%), lung (28%) and prostate (14%), ... radiotherapy in the week commencing 24 September 2007. We also collected information on cancer site, so that patients could be triaged into the 22 categories used by the National ... opinion about treatment options. This will be essential for long-term planning as cancer incidence increases over the next decade, but it does not weaken the conclusion that there is a ...
2009 NOV 23 ... "One of the recent advances in the treatment of breastcancer is trastuzumab. However, a major side effect of this medication is ... in the United States report. "Our objective was to determine the incidence of trastuzumab-induced cardiomyopathy and the rate of discontinuation of trastuzumab in ...
2009 NOV 16 ... of unexpected focal F-18-fluorodeoxyglucose (FDG) uptake localized by PET/ CT within the breast. The files of 4,038 consecutive female cancer patients referred for FDG PET/CT over a ... Israel report. "with breast cancer were excluded from the study. The incidence of focal sites of increased FDG uptake localized by PET/CT to the breast was determined. ...
2009 NOV 16 ... Current study results from the report, 'Radiological staging in breastcancer: which asymptomatic patients to image and how,' have been published. ... Conversely, 2.2, 2.6 and 3.8% of these groups had false-positive results. The incidence of occult metastases increased by stage, being present in 6, 13.9 and 57% of patients ...
2009 NOV 16 ... "As chemotherapy and molecular therapy improve the systemic survival of breastcancer patients, the incidence of brain metastases increases. Few therapeutic strategies ...
2009 NOV 23 ... p=0.003). Great increase of incidence by time was found (R(2)=0.90; p=0.004). Breast, prostate and bladder cancers increase risk of second tumor in female genital organs [RR ... Researchers detail in 'Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors,' new data ...
2009 NOV 16 ... According to a study from Norway, "Secondary tumours in the breast are rare. Based on literature, an incidence of 0.4-2% is reported." "In ... is of crucial importance. Melanoma markers (Melan-A, HMB-45, S-100 protein), lung cancer markers (Cytokeratins, TTF1, Chromogranin, Synapthophysin) and lymphoid markers (CD3, ...
2009 NOV 16 ... According to recent research from Taiwan, "Within the past decade, the incidence of breastcancer in Taiwan has been rising year after year. Breastcancer is the first most ...
2009 NOV 16 ... According to a study from the United States, "Breastcancer in females and prostate cancer in males are two of the most common cancers in the ... "We analyzed Caucasian age-adjusted county level average annual incidence rates for breast and prostate cancers from the National Cancer Institute and State ...
2009 NOV 23 ... II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breastcancer patients after anthracycline and taxane treatment,' is the subject of a report. ... Patients were treated with gemcitabine on days 1 and 8 of a 21-day cycle and explored incidence of adverse events graded by Common Terminology Criteria for Adverse Events (CTCAE) ...
2009 NOV 23 ... chemotherapy segments of the market will be offset by a 1.2 percent annual increase in breast cancer incidence in the world's major markets and by the launch and uptake of premium-priced agents. ...
2009 NOV 16 ... According to a study from the United States, "Brain metastases of breastcancer seem to be increasing in incidence as systemic therapy improves. Metastatic ...
2009 NOV 23 ... Medicine, "Paclitaxel is a chemotherapeutic agent used for the treatment of metastatic breastcancer. 2,5,7,8-Tetramethyl-2R-(4R, 8R-12-trimethyltridecyl) chroman-6-yloxyacetic acid ... acid (a-TEA) is an analog of vitamin E that inhibits primary tumor growth and the incidence of lymphatic and pulmonary metastases in preclinical animal models. Here, the efficacy ...
2009 NOV 16 ... A new study, 'Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breastcancer,' is now available. "In this report, we describe a patient with a de novo BRCA2 ... Cancer Mutation database. This finding illustrates the importance of determining the incidence of de novo BRCA mutations and is of significant clinical value to breast cancer ...
2009 NOV 23 ... "Estrogen plus progestin therapy increases breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus progestin therapy ...
2009 NOV 16 ... The Voices Of book series was conceptualized by Debra LaChance who, when diagnosed with breastcancer, sought out the personal stories of those who had been through what she was ... of African, Asian, and Hispanic backgrounds are also diagnosed with MS; however, the incidence is much lower. Voices of Multiple Sclerosis and all of the Voices Of books ...
